Skip to main content
. 2023 Oct 2;10:1229148. doi: 10.3389/fmed.2023.1229148

Figure 2.

Figure 2

Tornado diagrams show the results of the deterministic sensitivity analyses. (A) FMT vs. vancomycin in overall rCDI patients from the payer's perspective. (B) FMT vs. fidaxomicin in overall rCDI patients from the payer's perspective (increases are shown in red and decreases in blue, when the parameter values were changed). FMT, fecal microbiota transplantation; rCDI, refractory or recurrent Clostridioides difficile infection.